Indonesia Frailty, Aging, and Longitudinal Study (INA-FRAGILE)

August 24, 2015 updated by: Siti Setiati, Indonesia University

Frailty is a dynamic process from fit (robust) and pre-frail elderly. There is no previous study that determine the risk factors from fit to pre-frailty and pre-frailty to frailty in Indonesian elderly.

This study was aimed to define the risk factors and clinical outcomes of frailty transitional status in Indonesian elderly.

Study Overview

Status

Unknown

Detailed Description

Frailty is an age-associated, biological syndrome characterized by decreased biological reserves, due to dysregulation of several physiological systems, which puts an individual at risk when facing minor stressors, and is associated with poor outcomes (ie, disability, death, and hospitalization).

Frailty identifies a high-risk subgroup and offers characteristics of great clinical importance: a higher reversibility at early stages than disability, and a higher predictive value than chronic disease for adverse outcomes at older ages. It is also the most common condition leading to death in community-dwelling older people.

However, there is current consensus that physical frailty is potentially reversible. It is hence useful to objectively detect frailty among frail elderly persons, as frailty indices serve a useful purpose for risk stratification, predicting need for institutional care and planning of services needed.

To date, there is no study or information about frailty status in Indonesia elderly. This study was aimed to define the risk factors and clinical outcomes of frailty transitional status in Indonesian elderly.

Study Type

Observational

Enrollment (Anticipated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jakarta, Indonesia
        • Recruiting
        • Comprehensive Geriatric Clinic, Cipto Mangunkusumo Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Fit or pre-frail elderly aged >= 60 years old who came to Comprehensive Geriatric Clinics, Cipto Mangunkusumo General Hospital, Jakarta, during March 2015-March 2016.

Description

Inclusion Criteria:

  1. Elderly aged >= 60 years old
  2. Fit (robust) or pre-frailty;
  3. Capable to understand and carry-out the instruction.

Exclusion Criteria:

  1. Unwilling to join the study;
  2. Abbreviated Mental Test (AMT) score < 8;
  3. Geriatric Depression Scale (GDS) score >= 10;
  4. Body mass index (BMI) <18,5 Kg/m2;
  5. Malnutrition (according to Mini Nutritional Assessment/MNA);
  6. Liver cirrhosis, severe liver dysfunction, or serum ALT levels >3 times upper normal limit;
  7. Acute illness during inclusion period, eg. pneumonia, pain due to acute arthritis (visual analog scale >6/10), stroke attack, crisis hypertension;
  8. Severe cardiac dysfunction: acute decompensated heart failure and/or chronic heart failure functional class III or IV (New York Heart Association classification);
  9. Severe pulmonary dysfunction: acute exacerbation of chronic obstructive lung disease stage III or IV (GOLD classification), and/or PaO2 levels < 60 mmHg.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in frailty status at 1 year
Time Frame: Baseline and at 1 year
Frailty status is divided into Fit (robust), Pre-frail, and Frailty.
Baseline and at 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in health-related quality of life at 1 year
Time Frame: Baseline and at 1 year
Health-related quality of life: using Euro Quality of Life-5 Dimension (EQ-5D) questionnaire.
Baseline and at 1 year
Change from baseline in fall incidence at 1 year
Time Frame: Baseline and at 1 year
Fall incidence: number of fall during observational period.
Baseline and at 1 year
Change from baseline in hospitality at 1 year
Time Frame: Baseline and at 1 year
Hospitality: number of hospital admission (emergency or inpatient care) during observational period.
Baseline and at 1 year
Change from baseline in mortality at 1 year
Time Frame: Baseline and at 1 year
Mortality: number of subjects died after 1 year observation.
Baseline and at 1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in handgrip strength at 1 year
Time Frame: Baseline and at 1 year
Measurement: using Jamar Hydraulic Hand Dynamometer Model J00105
Baseline and at 1 year
Change from baseline in gait speed at 1 year
Time Frame: Baseline and at 1 year
Measurement: 15-feet walking test
Baseline and at 1 year
Change from baseline in functional status at 1 year
Time Frame: Baseline and at 1 year
Measurement: Barthel Index Activities of Daily Living (B-ADL) & Lawton Instrumental & Activities of Daily Living (L-IADL) questionnaires.
Baseline and at 1 year
Change from baseline in cognitive status at 1 year
Time Frame: Baseline and at 1 year
Measurement: Abbreviated mental test (AMT) questionnaire.
Baseline and at 1 year
Change from baseline in mental status at 1 year
Time Frame: Baseline and at 1 year
Measurement: Short Form Geriatric Depression Scale (GDS) questionnaire.
Baseline and at 1 year
Change from baseline in nutritional status at 1 year
Time Frame: Baseline and at 1 year
Measurement: Mini Nutritional Assessment (MNA) questionnaire.
Baseline and at 1 year
Change from baseline in sarcopenia status at 1 year
Time Frame: Baseline and at 1 year
Categories: no sarcopenia, pre-sarcopenia, sarcopenia, and severe sarcopenia.
Baseline and at 1 year
Change from baseline in comorbidities status at 1 year
Time Frame: Baseline and at 1 year
Measurement: Cumulative Illness Rating Scale (CIRS)
Baseline and at 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Siti Setiati, Prof, MD, Division of Geriatrics, Department of Internal Medicine, Universitas Indonesia-Cipto Mangunkusumo General Hospital, Jakarta
  • Study Chair: Purwita Laksmi, MD, Division of Geriatrics, Department of Internal Medicine, Universitas Indonesia-Cipto Mangunkusumo General Hospital, Jakarta
  • Study Chair: Rahmi Istanti, SKM, MARS, Division of Geriatrics, Department of Internal Medicine, Universitas Indonesia-Cipto Mangunkusumo General Hospital, Jakarta
  • Study Chair: Tirza Tamin, MD, PhD, Department of Rehabilitation & Physical Medicine, Universitas Indonesia-Cipto Mangunkusumo General Hospital, Jakarta

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2015

Primary Completion (Anticipated)

March 1, 2016

Study Completion (Anticipated)

August 1, 2016

Study Registration Dates

First Submitted

January 19, 2015

First Submitted That Met QC Criteria

January 19, 2015

First Posted (Estimate)

January 26, 2015

Study Record Updates

Last Update Posted (Estimate)

August 26, 2015

Last Update Submitted That Met QC Criteria

August 24, 2015

Last Verified

August 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Subscribe